Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05038800 |
| Title | A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) (MK-0482-002) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme Corp. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Roswell Park Cancer Institute ( Site 0006) | Buffalo | New York | 14263 | United States | Details | |
| University of Texas MD Anderson Cancer Center ( Site 0004) | Houston | Texas | 77030 | United States | Details | |
| Hadassah Medical Center ( Site 0100) | Jerusalem | 9112001 | Israel | Details | ||
| Sheba Medical Center-Hemato Oncology ( Site 0101) | Ramat Gan | 5262100 | Israel | Details | ||
| Hospital Universitario de Salamanca - Complejo Asistencial U-Servicio de Hematologia ( Site 0301) | Salamanca | 37007 | Spain | Details |